NALDEMEDINE

NALDEMEDINE was reported 894 times

NALDEMEDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SEPTIC COAGULOPATHY 1 0.2500
1 SPHENOPALATINE NEURALGIA 1 0.2500
2 INTERNAL CAROTID ARTERY DEFORMITY 1 0.1667
3 POST-THORACOTOMY PAIN SYNDROME 1 0.0909
4 HER2 POSITIVE GASTRIC CANCER 1 0.0714
5 DUODENAL VASCULAR ECTASIA 1 0.0667
6 CHOROID NEOPLASM 1 0.0625
7 ENTEROCOLITIS FUNGAL 1 0.0526
8 INTENSIVE CARE UNIT DELIRIUM 1 0.0476
9 TUMOUR CAVITATION 1 0.0435
10 IMMUNE-MEDIATED GASTRITIS 1 0.0357
11 IMMUNE-MEDIATED HYPERTHYROIDISM 1 0.0345
12 METASTATIC BRONCHIAL CARCINOMA 5 0.0336
13 HAEMORRHAGIC TUMOUR NECROSIS 1 0.0294
14 INTESTINAL METASTASIS 5 0.0292
15 AMOEBIC DYSENTERY 2 0.0270
16 PARALYSIS RECURRENT LARYNGEAL NERVE 2 0.0250
17 IMMUNE-MEDIATED CHOLANGITIS 1 0.0200
18 METASTASES TO STOMACH 5 0.0171
19 TUMOUR PERFORATION 3 0.0160
20 COLORECTAL CANCER RECURRENT 1 0.0154
21 BLADDER TAMPONADE 3 0.0143
22 SILENT THYROIDITIS 1 0.0143
23 ORAL VIRAL INFECTION 1 0.0137
24 CYTOMEGALOVIRUS GASTROENTERITIS 2 0.0137
25 IMMUNE-MEDIATED NEPHRITIS 1 0.0132
26 RETROPERITONEAL NEOPLASM 1 0.0132
27 BRONCHOSTENOSIS 5 0.0130
28 METASTASES TO PANCREAS 4 0.0129
29 GINGIVAL CANCER 1 0.0125
30 CEREBROSPINAL FLUID RETENTION 1 0.0125
31 PURPURA SENILE 1 0.0119
32 PRODUCT IDENTIFICATION NUMBER ISSUE 1 0.0118
33 FAECALITH 1 0.0116
34 OPEN GLOBE INJURY 1 0.0104
35 IMMUNE-MEDIATED ARTHRITIS 1 0.0102
36 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 1 0.0098
37 IMMUNE-MEDIATED DERMATITIS 1 0.0093
38 IMMUNE-MEDIATED HEPATIC DISORDER 3 0.0090
39 IMMUNE-MEDIATED PNEUMONITIS 2 0.0081
40 THROMBOPHLEBITIS MIGRANS 1 0.0080
41 NECROTISING SOFT TISSUE INFECTION 1 0.0077
42 ADRENOMEGALY 1 0.0074
43 IMMUNE-MEDIATED ENTEROCOLITIS 6 0.0074
44 IMMUNE-MEDIATED HYPOTHYROIDISM 1 0.0072
45 CONTRAINDICATED DRUG PRESCRIBED 2 0.0071
46 SECONDARY HYPOTHYROIDISM 1 0.0068
47 LARYNGEAL INFLAMMATION 1 0.0068
48 MESENTERIC VEIN THROMBOSIS 5 0.0067
49 BRONCHIAL FISTULA 1 0.0063
50 PLEURAL INFECTION 1 0.0057
51 SEROUS RETINAL DETACHMENT 2 0.0056
52 HYPONATRAEMIC SEIZURE 1 0.0055
53 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 2 0.0052
54 THYROIDITIS SUBACUTE 1 0.0050
55 INFECTIVE SPONDYLITIS 1 0.0048
56 BLADDER INJURY 1 0.0048
57 PLANTAR ERYTHEMA 1 0.0048
58 CLEAR CELL RENAL CELL CARCINOMA 2 0.0045
59 FULMINANT TYPE 1 DIABETES MELLITUS 2 0.0043
60 CHOLANGITIS SCLEROSING 5 0.0041
61 ENTEROCOCCUS TEST POSITIVE 2 0.0041
62 SMALL CELL CARCINOMA 1 0.0040
63 TACHYCARDIA PAROXYSMAL 1 0.0040
64 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0040
65 LYMPHANGIOSIS CARCINOMATOSA 3 0.0038
66 ECTHYMA 1 0.0038
67 METASTATIC CARCINOMA OF THE BLADDER 1 0.0038
68 LARGE INTESTINAL ULCER HAEMORRHAGE 1 0.0037
69 MOUTH BREATHING 1 0.0036
70 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 1 0.0036
71 ANASTOMOTIC COMPLICATION 1 0.0035
72 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 2 0.0035
73 FAECAL VOLUME DECREASED 1 0.0035
74 COMPUTERISED TOMOGRAM THORAX ABNORMAL 2 0.0034
75 MIXED CONNECTIVE TISSUE DISEASE 1 0.0034
76 HAEMOBILIA 1 0.0033
77 BLOOD CORTICOTROPHIN DECREASED 1 0.0033
78 BLADDER PERFORATION 1 0.0033
79 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0031
80 MECHANICAL ILEUS 1 0.0031
81 CANCER PAIN 5 0.0030
82 POSTRENAL FAILURE 1 0.0029
83 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 1 0.0028
84 BONE CANCER METASTATIC 1 0.0027
85 GALLBLADDER CANCER 3 0.0026
86 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 1 0.0026
87 ADRENAL HAEMORRHAGE 1 0.0026
88 TUMOUR NECROSIS 2 0.0026
89 THERAPEUTIC RESPONSE INCREASED 2 0.0025
90 TUMOUR HAEMORRHAGE 5 0.0025
91 SPINAL EPIDURAL HAEMATOMA 1 0.0025
92 PROSTATE CANCER RECURRENT 1 0.0025
93 EOSINOPHILIC MYOCARDITIS 1 0.0025
94 CHOLANGITIS 10 0.0025
95 ANISOCYTOSIS 1 0.0024
96 HEPATOBILIARY DISEASE 1 0.0024
97 WATER INTOXICATION 1 0.0023
98 GASTROINTESTINAL WALL THICKENING 2 0.0023
99 PNEUMOTHORAX SPONTANEOUS 1 0.0022
100 SMALL CELL LUNG CANCER 2 0.0022
101 SUPERIOR VENA CAVA SYNDROME 1 0.0022
102 RADIATION SKIN INJURY 2 0.0021
103 DUODENAL ULCER HAEMORRHAGE 5 0.0021
104 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0021
105 CHOLANGITIS ACUTE 1 0.0020
106 HEAD AND NECK CANCER 1 0.0020
107 NASAL SEPTUM PERFORATION 1 0.0020
108 ILEAL PERFORATION 1 0.0020
109 PERIPHERAL MOTOR NEUROPATHY 2 0.0020
110 GASTROINTESTINAL PERFORATION 6 0.0019
111 CORTISOL DECREASED 1 0.0019
112 EMBOLIC CEREBRAL INFARCTION 1 0.0019
113 METASTASES TO LYMPH NODES 8 0.0018
114 CLONIC CONVULSION 1 0.0018
115 TUMOUR LYSIS SYNDROME 10 0.0018
116 SQUAMOUS CELL CARCINOMA OF LUNG 1 0.0017
117 HEMIANOPIA HOMONYMOUS 1 0.0017
118 PULMONARY ARTERY THROMBOSIS 1 0.0017
119 GINGIVAL ABSCESS 1 0.0017
120 INFREQUENT BOWEL MOVEMENTS 3 0.0017
121 ENTEROCOLITIS 6 0.0017
122 PRODUCT PACKAGING QUANTITY ISSUE 9 0.0017
123 INAPPROPRIATE PRESCRIBING 1 0.0016
124 PHYSICAL PRODUCT LABEL ISSUE 1 0.0015
125 SEPTIC EMBOLUS 1 0.0015
126 PNEUMONIA CYTOMEGALOVIRAL 2 0.0015
127 IMMUNE-MEDIATED HEPATITIS 1 0.0015
128 PROTEIN URINE 1 0.0015
129 IMMUNE THROMBOCYTOPENIA 2 0.0015
130 JC POLYOMAVIRUS TEST POSITIVE 1 0.0014
131 HYPOPHYSITIS 2 0.0014
132 PRINZMETAL ANGINA 1 0.0014
133 CANDIDA SEPSIS 1 0.0014
134 OVARIAN CANCER RECURRENT 1 0.0014
135 RECTAL TENESMUS 1 0.0014
136 INTERSTITIAL LUNG DISEASE 45 0.0013
137 GASTROINTESTINAL TRACT IRRITATION 1 0.0013
138 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0013
139 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0013
140 URINARY BLADDER HAEMORRHAGE 2 0.0013
141 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0012
142 PHARYNGEAL INFLAMMATION 1 0.0012
143 PHYSICAL DECONDITIONING 1 0.0012
144 NEPHROGENIC DIABETES INSIPIDUS 1 0.0012
145 MARASMUS 1 0.0012
146 PERIODONTITIS 2 0.0012
147 PALMAR ERYTHEMA 1 0.0012
148 DELIRIUM 28 0.0011
149 INFECTIOUS PLEURAL EFFUSION 1 0.0011
150 OCCULT BLOOD POSITIVE 2 0.0011
151 BILE DUCT STENOSIS 1 0.0011
152 EMBOLISM ARTERIAL 1 0.0011
153 DIFFUSE ALVEOLAR DAMAGE 1 0.0011
154 BILE DUCT CANCER 1 0.0011
155 PSEUDOMEMBRANOUS COLITIS 2 0.0011
156 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0011
157 MYOCLONIC EPILEPSY 1 0.0010
158 DYSPNOEA AT REST 2 0.0010
159 CEREBRAL ARTERY EMBOLISM 1 0.0010
160 INTERNATIONAL NORMALISED RATIO ABNORMAL 3 0.0010
161 PANCREATIC ENZYMES INCREASED 1 0.0010
162 HYPERTROPHIC CARDIOMYOPATHY 1 0.0010
163 LUNG ADENOCARCINOMA 2 0.0009
164 MALIGNANT NEOPLASM PROGRESSION 62 0.0009
165 GASTROINTESTINAL HYPOMOTILITY 1 0.0009
166 ALLERGIC REACTION TO EXCIPIENT 1 0.0009
167 HEPATIC FUNCTION ABNORMAL 23 0.0009
168 DEVICE ALARM ISSUE 1 0.0009
169 RESPIRATORY ALKALOSIS 1 0.0009
170 VASCULAR INJURY 1 0.0009
171 HEPATITIS FULMINANT 2 0.0009
172 ERYTHEMA MULTIFORME 6 0.0008
173 FAECES HARD 2 0.0008
174 ILEUS 7 0.0008
175 DEPRESSION SUICIDAL 2 0.0008
176 APLASIA PURE RED CELL 2 0.0008
177 PRODUCT COMMUNICATION ISSUE 1 0.0008
178 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0008
179 ANAL INCONTINENCE 4 0.0008
180 SPINAL COMPRESSION FRACTURE 5 0.0008
181 TOBACCO USER 1 0.0007
182 METASTASES TO MENINGES 1 0.0007
183 PNEUMONIA BACTERIAL 4 0.0007
184 METASTASES TO LIVER 9 0.0007
185 PRODUCT LOT NUMBER ISSUE 1 0.0007
186 ACUTE SINUSITIS 1 0.0007
187 SUDDEN HEARING LOSS 1 0.0007
188 OPPORTUNISTIC INFECTION 1 0.0007
189 SKIN ABRASION 2 0.0007
190 CHOLECYSTITIS ACUTE 3 0.0007
191 HYPERBILIRUBINAEMIA 5 0.0007
192 ANORECTAL DISORDER 1 0.0007
193 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0007
194 INADEQUATE ANALGESIA 5 0.0007
195 HYPERCOAGULATION 1 0.0006
196 NEUTROPHIL COUNT DECREASED 17 0.0006
197 DRUG EFFECT INCREASED 2 0.0006
198 METASTASES TO PERITONEUM 1 0.0006
199 FOOD POISONING 2 0.0006
200 HYPERTENSIVE HEART DISEASE 1 0.0006
201 RECTAL DISCHARGE 2 0.0006
202 ADRENAL INSUFFICIENCY 4 0.0006
203 GASTROINTESTINAL OBSTRUCTION 1 0.0006
204 VENOUS THROMBOSIS LIMB 1 0.0006
205 SUBILEUS 1 0.0006
206 DIVERTICULAR PERFORATION 1 0.0006
207 ADENOCARCINOMA 1 0.0006
208 SMALL INTESTINE CARCINOMA 1 0.0006
209 PHARYNGEAL ERYTHEMA 1 0.0006
210 GASTROINTESTINAL ULCER 1 0.0006
211 MYASTHENIA GRAVIS 2 0.0006
212 MOUTH HAEMORRHAGE 3 0.0006
213 LONG QT SYNDROME 1 0.0006
214 LUNG NEOPLASM MALIGNANT 18 0.0005
215 COLON CANCER 6 0.0005
216 DEFAECATION URGENCY 2 0.0005
217 VOMITING PROJECTILE 1 0.0005
218 GASTRIC PERFORATION 1 0.0005
219 SPINAL STENOSIS 1 0.0005
220 LARGE INTESTINAL ULCER 1 0.0005
221 LACUNAR INFARCTION 1 0.0005
222 TYPE 1 DIABETES MELLITUS 2 0.0005
223 BREAKTHROUGH PAIN 1 0.0005
224 INSURANCE ISSUE 2 0.0005
225 HAEMATOLOGICAL MALIGNANCY 1 0.0005
226 FREQUENT BOWEL MOVEMENTS 8 0.0005
227 NEOPLASM MALIGNANT 23 0.0005
228 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0005
229 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0005
230 SKIN EROSION 1 0.0005
231 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0005
232 ALTERED STATE OF CONSCIOUSNESS 7 0.0005
233 HYPERCAPNIA 1 0.0005
234 ATYPICAL FEMUR FRACTURE 1 0.0005
235 STRABISMUS 1 0.0005
236 RECTAL CANCER 1 0.0005
237 CHOLECYSTITIS 4 0.0004
238 BREAST CANCER RECURRENT 1 0.0004
239 LIVER ABSCESS 1 0.0004
240 METASTASES TO SPINE 1 0.0004
241 PROSTATITIS 1 0.0004
242 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
243 TASTE DISORDER 3 0.0004
244 PRODUCT ADMINISTRATION ERROR 4 0.0004
245 POSTOPERATIVE WOUND INFECTION 2 0.0004
246 LUMBAR SPINAL STENOSIS 1 0.0004
247 PANCREATIC CARCINOMA METASTATIC 1 0.0004
248 ABDOMINAL PAIN 71 0.0004
249 PANCREATIC CARCINOMA 9 0.0004
250 AUTOIMMUNE HEPATITIS 2 0.0004
251 DRUG-INDUCED LIVER INJURY 7 0.0004
252 EXPOSURE VIA INGESTION 1 0.0004
253 NON-SMALL CELL LUNG CANCER 1 0.0004
254 NECROTISING FASCIITIS 1 0.0004
255 CYTOKINE RELEASE SYNDROME 2 0.0004
256 INJECTION SITE INFECTION 1 0.0004
257 PNEUMONITIS 7 0.0004
258 HYPERKALAEMIA 10 0.0004
259 BRONCHIOLITIS 1 0.0004
260 PEPTIC ULCER 1 0.0004
261 FOOD CRAVING 1 0.0004
262 MYELOSUPPRESSION 2 0.0004
263 CONSTIPATION 53 0.0004
264 CEREBRAL INFARCTION 7 0.0004
265 VITAMIN B12 DEFICIENCY 1 0.0004
266 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0004
267 INTESTINAL PERFORATION 3 0.0004
268 CLAVICLE FRACTURE 1 0.0004
269 LIVER DISORDER 11 0.0004
270 ANAL FISSURE 1 0.0003
271 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0003
272 ABSCESS LIMB 1 0.0003
273 CAROTID ARTERY STENOSIS 1 0.0003
274 CERVIX CARCINOMA 1 0.0003
275 FEBRILE NEUTROPENIA 15 0.0003
276 AGRANULOCYTOSIS 4 0.0003
277 DIARRHOEA 149 0.0003
278 HYPERURICAEMIA 1 0.0003
279 ORGANISING PNEUMONIA 1 0.0003
280 VENOUS THROMBOSIS 1 0.0003
281 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0003
282 ATRIAL FLUTTER 2 0.0003
283 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
284 LUNG DISORDER 11 0.0003
285 BRAIN NEOPLASM 2 0.0003
286 HEPATIC PAIN 1 0.0003
287 LUMBAR VERTEBRAL FRACTURE 1 0.0003
288 ABDOMINAL ABSCESS 1 0.0003
289 PRESCRIBED UNDERDOSE 4 0.0003
290 PULMONARY TUBERCULOSIS 1 0.0003
291 UTERINE CANCER 2 0.0003
292 METASTASES TO BONE 3 0.0003
293 VITAMIN D DEFICIENCY 2 0.0003
294 PLATELET COUNT DECREASED 21 0.0003
295 PROTEIN URINE PRESENT 1 0.0003
296 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0003
297 STEVENS-JOHNSON SYNDROME 5 0.0003
298 GASTROINTESTINAL MOTILITY DISORDER 1 0.0003
299 HAEMOPTYSIS 6 0.0003
300 ANAL FISTULA 1 0.0003
301 HYPERNATRAEMIA 1 0.0003
302 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0003
303 SUPRAVENTRICULAR TACHYCARDIA 2 0.0003
304 FEEDING DISORDER 3 0.0003
305 PNEUMOTHORAX 3 0.0003
306 FEMORAL NECK FRACTURE 1 0.0003
307 ISCHAEMIA 1 0.0003
308 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0003
309 CORONAVIRUS INFECTION 1 0.0003
310 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0003
311 DRUG TOLERANCE 1 0.0003
312 HEART RATE ABNORMAL 1 0.0003
313 PULMONARY THROMBOSIS 2 0.0003
314 CACHEXIA 1 0.0003
315 PULMONARY TOXICITY 1 0.0003
316 EMPHYSEMA 2 0.0003
317 DRUG ERUPTION 3 0.0003
318 DEVICE RELATED INFECTION 3 0.0002
319 ENTERITIS 1 0.0002
320 URINARY RETENTION 6 0.0002
321 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
322 GINGIVITIS 1 0.0002
323 AMMONIA INCREASED 1 0.0002
324 CORONARY ARTERY STENOSIS 1 0.0002
325 INABILITY TO AFFORD MEDICATION 1 0.0002
326 HAEMORRHAGIC ANAEMIA 1 0.0002
327 DRUG WITHDRAWAL SYNDROME 18 0.0002
328 CARDIAC FAILURE ACUTE 1 0.0002
329 MENISCUS INJURY 1 0.0002
330 HAEMATURIA 6 0.0002
331 PRODUCT PRESCRIBING ISSUE 1 0.0002
332 MYOCLONUS 2 0.0002
333 PROCTALGIA 1 0.0002
334 CARDIOGENIC SHOCK 2 0.0002
335 ENCEPHALITIS 1 0.0002
336 LYMPHOPENIA 2 0.0002
337 GASTRIC ULCER HAEMORRHAGE 1 0.0002
338 ACUTE HEPATIC FAILURE 2 0.0002
339 PHOTOPSIA 1 0.0002
340 PULMONARY CONGESTION 2 0.0002
341 NEPHROTIC SYNDROME 1 0.0002
342 PLEURISY 1 0.0002
343 MENINGITIS 1 0.0002
344 WHITE BLOOD CELL COUNT DECREASED 15 0.0002
345 MYOCARDIAL ISCHAEMIA 2 0.0002
346 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
347 GANGRENE 1 0.0002
348 COLITIS ISCHAEMIC 1 0.0002
349 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0002
350 OSTEONECROSIS OF JAW 4 0.0002
351 PLASMA CELL MYELOMA 5 0.0002
352 LARGE INTESTINE PERFORATION 1 0.0002
353 STOMATITIS 8 0.0002
354 JOINT EFFUSION 1 0.0002
355 MAJOR DEPRESSION 1 0.0002
356 ANAEMIA 27 0.0002
357 DUODENAL ULCER 1 0.0002
358 THERMAL BURN 1 0.0002
359 HAEMATOTOXICITY 1 0.0002
360 PAROSMIA 1 0.0002
361 HYDRONEPHROSIS 1 0.0002
362 FACIAL PARALYSIS 1 0.0002
363 NEURALGIA 3 0.0002
364 GRAFT VERSUS HOST DISEASE 1 0.0002
365 RENAL IMPAIRMENT 10 0.0002
366 INTENTIONAL UNDERDOSE 1 0.0002
367 GENERALISED ERYTHEMA 1 0.0002
368 PLEURAL EFFUSION 8 0.0002
369 DECREASED APPETITE 27 0.0002
370 SCRATCH 1 0.0002
371 GASTRIC CANCER 3 0.0002
372 EOSINOPHIL COUNT INCREASED 1 0.0002
373 CYTOMEGALOVIRUS INFECTION 2 0.0002
374 BACK DISORDER 2 0.0002
375 LIPASE INCREASED 1 0.0002
376 MYOSITIS 1 0.0002
377 WITHDRAWAL SYNDROME 5 0.0002
378 HYPOPHAGIA 3 0.0002
379 MUSCULOSKELETAL DISCOMFORT 2 0.0002
380 BONE MARROW FAILURE 3 0.0002
381 PNEUMONIA ASPIRATION 3 0.0002
382 SEPTIC SHOCK 5 0.0002
383 THROMBOTIC MICROANGIOPATHY 1 0.0002
384 NASAL DISCOMFORT 1 0.0002
385 BLOOD POTASSIUM INCREASED 2 0.0002
386 PULMONARY HAEMORRHAGE 1 0.0002
387 PYELONEPHRITIS 1 0.0002
388 INTENTIONAL PRODUCT USE ISSUE 8 0.0002
389 APPENDICITIS 1 0.0002
390 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0002
391 INTESTINAL OBSTRUCTION 4 0.0002
392 SEROTONIN SYNDROME 2 0.0002
393 DRUG SCREEN POSITIVE 1 0.0002
394 EMBOLISM 1 0.0002
395 LEUKAEMIA 1 0.0002
396 HEMIPLEGIA 1 0.0002
397 ABDOMINAL DISTENSION 11 0.0002
398 HYPOCALCAEMIA 2 0.0001
399 IRON DEFICIENCY ANAEMIA 1 0.0001
400 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
401 FLANK PAIN 1 0.0001
402 EPILEPSY 3 0.0001
403 PRESCRIBED OVERDOSE 2 0.0001
404 ABDOMINAL PAIN UPPER 21 0.0001
405 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
406 FRACTURE 2 0.0001
407 RESTLESS LEGS SYNDROME 2 0.0001
408 PURPURA 1 0.0001
409 HALLUCINATION, VISUAL 2 0.0001
410 DYSURIA 4 0.0001
411 SPINAL DISORDER 1 0.0001
412 BLOOD BILIRUBIN INCREASED 3 0.0001
413 EYELID PTOSIS 1 0.0001
414 UNEVALUABLE EVENT 8 0.0001
415 OSTEOMYELITIS 2 0.0001
416 BURSITIS 1 0.0001
417 GASTROINTESTINAL PAIN 1 0.0001
418 ASCITES 3 0.0001
419 GASTROINTESTINAL CARCINOMA 1 0.0001
420 TOXIC SKIN ERUPTION 1 0.0001
421 OSTEOARTHRITIS 4 0.0001
422 HYPERHIDROSIS 13 0.0001
423 BLADDER DISORDER 1 0.0001
424 DYSPHAGIA 9 0.0001
425 GASTRIC ULCER 2 0.0001
426 NEOPLASM PROGRESSION 3 0.0001
427 LUNG INFILTRATION 1 0.0001
428 MALNUTRITION 1 0.0001
429 RENAL PAIN 1 0.0001
430 EATING DISORDER 2 0.0001
431 ATELECTASIS 1 0.0001
432 PANCYTOPENIA 5 0.0001
433 SEASONAL ALLERGY 1 0.0001
434 FLATULENCE 5 0.0001
435 DISEASE PROGRESSION 9 0.0001
436 MICTURITION URGENCY 1 0.0001
437 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
438 PERITONITIS BACTERIAL 1 0.0001
439 SEPSIS 10 0.0001
440 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
441 CYSTITIS 3 0.0001
442 SHOCK 2 0.0001
443 DERMATITIS ALLERGIC 1 0.0001
444 GAIT INABILITY 2 0.0001
445 FAECES DISCOLOURED 2 0.0001
446 HYPONATRAEMIA 5 0.0001
447 TOOTH DISORDER 2 0.0001
448 THERAPEUTIC RESPONSE DECREASED 5 0.0001
449 GENERALISED OEDEMA 1 0.0001
450 RHINORRHOEA 5 0.0001
451 ANAPHYLACTIC SHOCK 2 0.0001
452 MELAENA 2 0.0001
453 ENCEPHALOPATHY 2 0.0001
454 INTENTIONAL OVERDOSE 5 0.0001
455 ORAL CANDIDIASIS 1 0.0001
456 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
457 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
458 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
459 PYREXIA 28 0.0001
460 DEHYDRATION 11 0.0001
461 HIP ARTHROPLASTY 1 0.0001
462 HYPERCALCAEMIA 1 0.0001
463 RESPIRATORY DEPRESSION 1 0.0001
464 POST PROCEDURAL HAEMORRHAGE 1 0.0001
465 CEREBRAL HAEMORRHAGE 3 0.0001
466 NAUSEA 61 0.0001
467 HYPERGLYCAEMIA 3 0.0001
468 HYPOGLYCAEMIA 4 0.0001
469 LACRIMATION INCREASED 2 0.0001
470 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
471 MUCOSAL INFLAMMATION 2 0.0001
472 HEPATITIS 2 0.0001
473 GASTRIC HAEMORRHAGE 1 0.0001
474 INJECTION SITE RASH 2 0.0001
475 ABDOMINAL PAIN LOWER 2 0.0001
476 HAEMATEMESIS 2 0.0001
477 EYELID OEDEMA 1 0.0001
478 PULMONARY MASS 1 0.0001
479 GASTRITIS 2 0.0001
480 ACUTE KIDNEY INJURY 10 0.0001
481 RED BLOOD CELL COUNT DECREASED 2 0.0001
482 ABDOMINAL DISCOMFORT 11 0.0001
483 GENITAL HAEMORRHAGE 1 0.0001
484 HERPES ZOSTER 4 0.0001
485 ORAL DISCOMFORT 1 0.0001
486 INFUSION RELATED REACTION 4 0.0001
487 INJECTION SITE INDURATION 1 0.0001
488 THYROID DISORDER 1 0.0001
489 GASTROENTERITIS 1 0.0001
490 DISORIENTATION 3 0.0001
491 RESPIRATORY DISTRESS 2 0.0001
492 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
493 DRUG INTERACTION 11 0.0001
494 HYPOTHYROIDISM 2 0.0001
495 HYPOKALAEMIA 3 0.0001
496 OBESITY 1 0.0001
497 HYPOKINESIA 1 0.0001
498 DELUSION 1 0.0001
499 LIMB DISCOMFORT 2 0.0001
500 METABOLIC ACIDOSIS 2 0.0001
501 RESPIRATORY FAILURE 5 0.0001
502 DRUG INEFFECTIVE 84 0.0001
503 PRODUCT PRESCRIBING ERROR 1 0.0001
504 PNEUMONIA 20 0.0001
505 OESOPHAGEAL CARCINOMA 2 0.0001
506 PSYCHOTIC DISORDER 2 0.0001
507 ANKLE FRACTURE 1 0.0001
508 SUBDURAL HAEMATOMA 1 0.0001
509 RENAL DISORDER 3 0.0001
510 CARDIAC FAILURE 5 0.0001
511 COLITIS ULCERATIVE 2 0.0001
512 HIP FRACTURE 2 0.0001
513 ANGINA PECTORIS 2 0.0001
514 THIRST 1 0.0001
515 HEPATIC FAILURE 2 0.0001
516 RESPIRATORY ARREST 2 0.0001
517 BLOOD PRESSURE DECREASED 4 0.0001
518 CHILLS 7 0.0001
519 OXYGEN SATURATION DECREASED 3 0.0001
520 TENDONITIS 1 0.0001
521 COLITIS 2 0.0001
522 HAEMATOCHEZIA 3 0.0001
523 HYPOXIA 2 0.0001
524 C-REACTIVE PROTEIN INCREASED 2 0.0001
525 ORAL HERPES 1 0.0001
526 VENTRICULAR TACHYCARDIA 1 0.0001
527 BACTERIAL INFECTION 1 0.0001
528 MALAISE 26 0.0001
529 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
530 PROSTATE CANCER 5 0.0001
531 FACE OEDEMA 1 0.0001
532 MANIA 1 0.0001
533 BLOOD PRESSURE ABNORMAL 1 0.0001
534 LYMPHADENOPATHY 2 0.0001
535 ACUTE RESPIRATORY FAILURE 1 0.0001
536 IRRITABLE BOWEL SYNDROME 1 0.0001
537 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0001
538 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
539 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
540 LEUKOCYTOSIS 1 0.0001
541 MUSCLE SPASMS 10 0.0001
542 COLD SWEAT 1 0.0001
543 DISABILITY 1 0.0001
544 VOMITING 25 0.0001
545 BREAST CANCER 6 0.0001
546 THERAPY INTERRUPTED 1 0.0001
547 CIRCULATORY COLLAPSE 1 0.0001
548 SKIN CANCER 1 0.0001
549 OEDEMA PERIPHERAL 7 0.0001
550 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
551 SNEEZING 1 0.0001
552 BONE PAIN 3 0.0001
553 FOOT FRACTURE 1 0.0001
554 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0001
555 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0001
556 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
557 SLEEP APNOEA SYNDROME 1 0.0001
558 DRUG DISPENSING ERROR 1 0.0001
559 FEELING JITTERY 1 0.0001
560 NEUROPATHY PERIPHERAL 4 0.0001
561 RETCHING 1 0.0001
562 BODY TEMPERATURE INCREASED 1 0.0001
563 IRRITABILITY 3 0.0001
564 BALANCE DISORDER 4 0.0001
565 PERITONITIS 1 0.0001
566 MOBILITY DECREASED 3 0.0001
567 URTICARIA 7 0.0001
568 CONDITION AGGRAVATED 11 0.0001
569 PULMONARY HYPERTENSION 1 0.0001
570 NEUTROPENIA 5 0.0001
571 INJECTION SITE WARMTH 1 0.0001
572 DRUG RESISTANCE 1 0.0001
573 DISEASE RECURRENCE 1 0.0001
574 NO ADVERSE EVENT 6 0.0001
575 PRESYNCOPE 1 0.0001
576 COMA 2 0.0001
577 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0001
578 ARTHRITIS 3 0.0001
579 ADVERSE DRUG REACTION 3 0.0001
580 SOMNOLENCE 8 0.0001
581 DEMENTIA 1 0.0001
582 DIPLOPIA 1 0.0001
583 CELLULITIS 2 0.0001
584 PALLOR 1 0.0001
585 PULMONARY EMBOLISM 4 0.0001
586 HEPATIC CANCER 1 0.0001
587 HAEMOGLOBIN DECREASED 4 0.0001
588 RASH 15 0.0001
589 SPEECH DISORDER 2 0.0001
590 AGGRESSION 2 0.0000
591 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
592 DRUG INTOLERANCE 3 0.0000
593 MEDICATION ERROR 2 0.0000
594 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
595 HYPERSOMNIA 1 0.0000
596 FEELING COLD 1 0.0000
597 BACK PAIN 8 0.0000
598 ERYTHEMA 7 0.0000
599 TACHYCARDIA 3 0.0000
600 INFLUENZA LIKE ILLNESS 3 0.0000
601 DYSSTASIA 1 0.0000
602 SKIN DISORDER 1 0.0000
603 INSOMNIA 9 0.0000
604 BLOOD POTASSIUM DECREASED 1 0.0000
605 URINARY INCONTINENCE 1 0.0000
606 FEAR 1 0.0000
607 URINARY TRACT INFECTION 5 0.0000
608 BLADDER CANCER 2 0.0000
609 CARDIAC FAILURE CONGESTIVE 3 0.0000
610 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
611 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
612 STRESS 2 0.0000
613 NASOPHARYNGITIS 5 0.0000
614 SWOLLEN TONGUE 1 0.0000
615 FALL 10 0.0000
616 EMOTIONAL DISORDER 1 0.0000
617 OFF LABEL USE 18 0.0000
618 LIVER FUNCTION TEST ABNORMAL 1 0.0000
619 TREMOR 5 0.0000
620 DYSPNOEA EXERTIONAL 1 0.0000
621 ACCIDENTAL OVERDOSE 1 0.0000
622 HALLUCINATION 2 0.0000
623 GASTROINTESTINAL DISORDER 2 0.0000
624 STAPHYLOCOCCAL INFECTION 1 0.0000
625 PAIN 17 0.0000
626 DRY EYE 1 0.0000
627 DRUG EFFECT DECREASED 2 0.0000
628 DEEP VEIN THROMBOSIS 2 0.0000
629 VISUAL IMPAIRMENT 3 0.0000
630 HYPOAESTHESIA 4 0.0000
631 EPISTAXIS 2 0.0000
632 RESTLESSNESS 1 0.0000
633 CHEST PAIN 5 0.0000
634 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
635 PRURITUS 8 0.0000
636 DYSARTHRIA 1 0.0000
637 AGITATION 2 0.0000
638 VISUAL ACUITY REDUCED 1 0.0000
639 CRYING 1 0.0000
640 RASH ERYTHEMATOUS 1 0.0000
641 MUSCULOSKELETAL STIFFNESS 2 0.0000
642 DYSKINESIA 1 0.0000
643 PRODUCTIVE COUGH 1 0.0000
644 ROAD TRAFFIC ACCIDENT 1 0.0000
645 INTENTIONAL PRODUCT MISUSE 2 0.0000
646 PRODUCT STORAGE ERROR 1 0.0000
647 INFLAMMATION 1 0.0000
648 INFECTION 3 0.0000
649 NEPHROLITHIASIS 1 0.0000
650 MIGRAINE 2 0.0000
651 CARDIAC ARREST 2 0.0000
652 DEATH 18 0.0000
653 PULMONARY OEDEMA 1 0.0000
654 CARDIO-RESPIRATORY ARREST 1 0.0000
655 COGNITIVE DISORDER 1 0.0000
656 SKIN DISCOLOURATION 1 0.0000
657 THERAPY CESSATION 1 0.0000
658 DYSPNOEA 12 0.0000
659 ATRIAL FIBRILLATION 2 0.0000
660 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
661 TREATMENT NONCOMPLIANCE 1 0.0000
662 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
663 SURGERY 1 0.0000
664 MULTIPLE SCLEROSIS 1 0.0000
665 LEUKOPENIA 1 0.0000
666 ARRHYTHMIA 1 0.0000
667 RASH PRURITIC 1 0.0000
668 DISCOMFORT 1 0.0000
669 HYPERTENSION 4 0.0000
670 NASAL CONGESTION 1 0.0000
671 ARTHROPATHY 1 0.0000
672 OEDEMA 1 0.0000
673 FLUID RETENTION 1 0.0000
674 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
675 CATARACT 1 0.0000
676 COVID-19 1 0.0000
677 NECK PAIN 1 0.0000
678 INCORRECT DOSE ADMINISTERED 3 0.0000
679 PANCREATITIS 1 0.0000
680 FLUSHING 2 0.0000
681 MUSCULAR WEAKNESS 2 0.0000
682 RENAL CANCER 1 0.0000
683 PALPITATIONS 2 0.0000
684 ANXIETY 5 0.0000
685 HYPERSENSITIVITY 3 0.0000
686 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
687 PRODUCT SUBSTITUTION ISSUE 1 0.0000
688 HEPATIC ENZYME INCREASED 1 0.0000
689 CEREBROVASCULAR ACCIDENT 3 0.0000
690 ARTHRALGIA 6 0.0000
691 MUSCULOSKELETAL PAIN 1 0.0000
692 DIZZINESS 8 0.0000
693 FEELING ABNORMAL 4 0.0000
694 GAIT DISTURBANCE 3 0.0000
695 PERIPHERAL SWELLING 2 0.0000
696 WEIGHT DECREASED 4 0.0000
697 FATIGUE 11 0.0000
698 MEMORY IMPAIRMENT 2 0.0000
699 MYOCARDIAL INFARCTION 3 0.0000
700 HEADACHE 9 0.0000
701 OVERDOSE 3 0.0000
702 AMNESIA 1 0.0000
703 INJECTION SITE SWELLING 1 0.0000
704 UNDERDOSE 1 0.0000
705 INJECTION SITE BRUISING 1 0.0000
706 SKIN EXFOLIATION 1 0.0000
707 PARAESTHESIA 2 0.0000
708 DIABETES MELLITUS 1 0.0000
709 THROMBOSIS 1 0.0000
710 PRODUCT USE ISSUE 2 0.0000
711 MYALGIA 2 0.0000
712 OROPHARYNGEAL PAIN 1 0.0000
713 CHRONIC KIDNEY DISEASE 1 0.0000
714 ADVERSE EVENT 1 0.0000
715 SUICIDAL IDEATION 1 0.0000
716 SINUSITIS 1 0.0000
717 SEIZURE 1 0.0000
718 HYPOTENSION 2 0.0000
719 HAEMORRHAGE 1 0.0000
720 PAIN IN EXTREMITY 3 0.0000
721 BLOOD GLUCOSE INCREASED 2 0.0000
722 SYNCOPE 1 0.0000
723 RHEUMATOID ARTHRITIS 1 0.0000
724 THROMBOCYTOPENIA 1 0.0000
725 JOINT SWELLING 1 0.0000
726 PRODUCT DOSE OMISSION ISSUE 1 0.0000
727 PSORIASIS 1 0.0000
728 ASTHENIA 3 0.0000
729 INJECTION SITE ERYTHEMA 1 0.0000
730 HOSPITALISATION 1 0.0000
731 LOSS OF CONSCIOUSNESS 1 0.0000
732 VISION BLURRED 1 0.0000
733 INJECTION SITE PAIN 2 0.0000
734 RENAL FAILURE 1 0.0000
735 BLOOD PRESSURE INCREASED 1 0.0000
736 ALOPECIA 1 0.0000
737 DRUG HYPERSENSITIVITY 1 0.0000
738 DEPRESSION 1 0.0000
739 COUGH 1 0.0000